

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.348, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


CAD DM programme produces savings, incites criticism
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. :


CHF DM programme prolongs survival but no cost savings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :


Clinical success with CAD DM programme in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. :


Diabetes DM programme cost saving in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. :